Menu Search
Equities

Trupanion Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
TPW:STU

Trupanion Inc

Actions
  • Price (EUR)27.86
  • Today's Change-0.40 / -1.42%
  • Shares traded0.00
  • 1 Year change-36.52%
  • Beta1.5728
Data delayed at least 15 minutes, as of Feb 06 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Trupanion, Inc. is a medical insurance provider for cats and dogs throughout the United States, Canada, certain countries in Continental Europe, and Australia. The Company operates in two segments, namely, Subscription Business and Other Business. The Subscription Business segment includes subscription fees related to the Company's direct-to-consumer products. The Other Business segment comprises other product offerings that generally have a business-to-business relationship and a different margin profile than its subscription segment, including writing policies on behalf of third parties and other products and software solutions. It offers Trupanion, software that is designed to communicate directly with veterinary hospital's practice management software. It provides Powered by Trupanion pet insurance product offerings marketed by third parties and marketed under the brand names Furkin and PHI Direct in Canada, and a Trupanion branded product in Germany and Switzerland.

  • Revenue in USD (TTM)1.40bn
  • Net income in USD15.46m
  • Incorporated2006
  • Employees1.13k
  • Location
    Trupanion Inc6100 4Th Avenue South, Suite 400SEATTLE 98108United StatesUSA
  • Phone+1 (888) 738-7478
  • Fax+1 (302) 636-5454
  • Websitehttps://trupanion.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.